Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From

Felipe H Valle1, Shaun G Goodman1,2, Mary Tan2

  • 1Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

CJC Open
|January 7, 2022
PubMed

Insights

In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), dual-pathway therapy is used in about a quarter of cases, with increasing use over time. This therapy is chosen for patients with less complex coronary disease histories.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Balancing antithrombotic therapy risks (ischemia, stroke, bleeding) is crucial for atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI).
  • Understanding current treatment patterns is essential for optimizing patient care and outcomes in this high-risk population.

Purpose of the Study:

  • To determine the patterns of initial antithrombotic therapy selection in patients with AF undergoing PCI.
  • To analyze trends in the use of different antithrombotic regimens, including triple antithrombotic therapy (TAT) and dual-pathway therapy (DPT).

Main Methods:

  • A chart audit of 467 patients with AF undergoing PCI between December 2015 and July 2018 was conducted.
  • Data were collected by 47 Canadian cardiologists as part of the CONNECT AF+PCI study.
  • Initial antithrombotic therapy selection (TAT, DPT, dual antiplatelet therapy) was analyzed.

Main Results:

  • Triple antithrombotic therapy (TAT) was the initial choice for 62.7% of patients, followed by dual-pathway therapy (DPT) for 25.7%, and dual antiplatelet therapy for 11.6%.
  • Use of DPT showed a temporal increase during the study period.
  • Patients selected for DPT had less prior myocardial infarction and PCI but a higher prevalence of prior stroke/transient ischemic attack compared to those on TAT.

Conclusions:

  • Approximately one-quarter of AF patients undergoing PCI in Canadian practice receive dual-pathway therapy (DPT).
  • The utilization of DPT increased during the study period.
  • Patients receiving DPT generally presented with less complex coronary disease histories and interventions.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
46
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
46
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
59
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
51
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
64